THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

After transcatheter patent foramen ovale (PFO) closure, patients with nickel hypersensitivity were more likely to develop ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Blood test likened to a lateral flow test used to detect Covid is being piloted by ambulance crews in Cambridgeshire ...

Chronic stress can increase young women's risk of stroke, a new study says. Moderate stress increases risk of stroke by 78% ...

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

NHS pressures and “deep inequalities in care” are “failing” stroke patients, according to a report. The Stroke Association ...

With the recent report of increase in stroke cases observed after this holiday season by the Department of Health (DOH)1, ...

The Government of Taraba State has cleared the air on the whereabouts of Deputy Governor, Aminu Alkali. According to the ...